Cognito Therapeutics

• Brent Vaughan

  Chief Executive Officer

Sources: sec.gov

• Jeffrey Halis

  Board director

• Laura Brege

  Board director

• Richard Kuntz

  Board director

• Helen Liang

  Board director

• Gerald Chan

  Board director

• Stephen Bruso

  Board director

• Brent Vaughan

  Board director

Sources: sec.gov

• United States

Sources: sec.gov

• Series C

  $105M, Mar 6, 2026

• Form D

  $10.2M, Jun 18, 2024

• Venture

  $35M, Jan 30, 2024

• Series B

  $73M, Mar 31, 2023

• Form D

  $109M, Jun 16, 2022

Sources: news.google.com, sec.gov

• Apollo Health Ventures

• Morningside Ventures

  Series C, Lead, Mar 6, 2026

• WS Investment Company

  Series B, Mar 31, 2023

• IAG Capital

  Series B, Mar 31, 2023

• Starbloom Capital

  Series B, Mar 31, 2023

• ADDF

  Series B, Mar 31, 2023

• Alzheimer's Drug Discovery Foundation

  Series B, Mar 31, 2023

• FoundersX Ventures

  Series B, Lead, Mar 31, 2023

Sources: apollo.vc, news.google.com, wsgr.com

• Polygenic scores for longevity in relation to brain MRI measures in a cohort of 70-year-olds

  Consulting or advice, Board or leadership role, Oct 15, 2026

• CSF and plasma lipid profiling predicts risk of cognitive impairment in cognitively unimpaired older adults

  Consulting or advice, Oct 1, 2026

• Parental longevity and polygenic longevity scores in relation to ageing-related factors in a population of 70-year-olds followed over six years: The Gothenburg H70 Birth Cohort Study

  Consulting or advice, Board or leadership role, Sep 11, 2026

• Oligodendrocyte dysfunction in human age-related cognitive decline

  Consulting or advice, Fees or honoraria, Aug 25, 2026

• EPIC4ND-European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases

  Consulting or advice, Board or leadership role, Jul 22, 2026

• CSF and plasma tau biomarkers in the Down syndrome-Alzheimer's disease continuum

  Consulting or advice, Board or leadership role, Jul 11, 2026

• Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy

  Consulting or advice, Board or leadership role, Jul 1, 2026

• Sex-specific associations between astrocytic reactivity and cognitive decline in unimpaired elderly

  Consulting or advice, Board or leadership role, Jul 1, 2026

• Plasma proteomic profiles of Alzheimer's disease and neurodegeneration in African cohorts

  Consulting or advice, Board or leadership role, Jul 1, 2026

• Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathology

  Consulting or advice, Board or leadership role, Jun 26, 2026

• A multiverse analysis of the logical memory test and plasma biomarkers of Alzheimer's disease

  Consulting or advice, Board or leadership role, Jun 16, 2026

• Detecting amyloid-β pathology in subjective cognitive decline using plasma and CSF biomarkers

  Consulting or advice, Board or leadership role, Jun 16, 2026

• Interconnected influences of diet, gut microbiome, and metabolome on cognition across three metabolomics platforms

  Consulting or advice, Fees or honoraria, Jun 11, 2026

• Metabolic and renal factors associated with plasma phosphorylated tau analytes used to detect Alzheimer's disease pathology

  Consulting or advice, Fees or honoraria, Board or leadership role, Jun 7, 2026

• Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias

  Consulting or advice, Fees or honoraria, Board or leadership role, Jun 3, 2026

• Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort

  Consulting or advice, Board or leadership role, Jun 1, 2026

• Prevalence of high-risk plasma p-tau217 levels and 5-year transition of risk status in 70-year-olds

  Consulting or advice, Board or leadership role, Jun 1, 2026

• Association of LDL protein cargo with segmental pulse wave velocity in older adults in the atherosclerosis risk in communities study

  Consulting or advice, Board or leadership role, May 22, 2026

• CSF neurofilament light chain concentration in patients with delirium following hip fracture: a multicenter prospective study

  Consulting or advice, Board or leadership role, May 19, 2026

• Longitudinal Alterations in Sleep EEG Biomarkers of Memory Consolidation in Middle-Aged and Older Adults

  Consulting or advice, Board or leadership role, May 14, 2026

Sources: pubmed.ncbi.nlm.nih.gov, europepmc.org